On Monday, Biolife Solutions Inc (NASDAQ: BLFS) opened lower -4.51% from the last session, before settling in for the closing price of $22.84. Price fluctuations for BLFS have ranged from $18.70 to $29.55 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -55.83% over the past five years. Company’s average yearly earnings per share was noted 67.53% at the time writing. With a float of $45.63 million, this company’s outstanding shares have now reached $47.55 million.
Let’s look at the performance matrix of the company that is accounted for 159 employees. In terms of profitability, gross margin is 76.5%, operating margin of -5.27%, and the pretax margin is -9.78%.
Biolife Solutions Inc (BLFS) Insider Updates
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Biolife Solutions Inc is 4.07%, while institutional ownership is 99.15%. The most recent insider transaction that took place on Jun 16 ’25, was worth 15,806. In this transaction Chief Human Resources Officer of this company sold 711 shares at a rate of $22.23, taking the stock ownership to the 78,721 shares. Before that another transaction happened on Jun 16 ’25, when Company’s Officer proposed sale 711 for $22.03, making the entire transaction worth $15,663.
Biolife Solutions Inc (BLFS) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 67.53% per share during the next fiscal year.
Biolife Solutions Inc (NASDAQ: BLFS) Trading Performance Indicators
Check out the current performance indicators for Biolife Solutions Inc (BLFS). In the past quarter, the stock posted a quick ratio of 3.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.83. Likewise, its price to free cash flow for the trailing twelve months is 89.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.09 in one year’s time.
Technical Analysis of Biolife Solutions Inc (BLFS)
Biolife Solutions Inc (NASDAQ: BLFS) saw its 5-day average volume 0.63 million, a positive change from its year-to-date volume of 0.48 million. As of the previous 9 days, the stock’s Stochastic %D was 65.80%.
During the past 100 days, Biolife Solutions Inc’s (BLFS) raw stochastic average was set at 27.60%, which indicates a significant decrease from 46.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.28% in the past 14 days, which was lower than the 62.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.64, while its 200-day Moving Average is $24.52. Nevertheless, the first resistance level for the watch stands at $22.58 in the near term. At $23.34, the stock is likely to face the second major resistance level. The third major resistance level sits at $23.78. If the price goes on to break the first support level at $21.38, it is likely to go to the next support level at $20.94. Assuming the price breaks the second support level, the third support level stands at $20.18.
Biolife Solutions Inc (NASDAQ: BLFS) Key Stats
There are currently 47,500K shares outstanding in the company with a market cap of 1.04 billion. Presently, the company’s annual sales total 82,250 K according to its annual income of -20,180 K. Last quarter, the company’s sales amounted to 23,940 K and its income totaled -450 K.
